News

Stille AB (publ) (“Stille”) has entered into an agreement to acquire all shares outstanding in Surgical Holdings (“Surgical Holdings”) for a consideration of approximately GBP 7.7 million (corresponding to SEK 100 million) on a cash and debt-free basis. Through the acquisition, Stille continues its strategic expansion, further strengthening its geographic reach, product- and...

Torshälla, Sweden – 9 May 2025 – The Board of Directors of Stille AB (“Stille”), a leading provider of premium surgical instruments and advanced surgical tables for high-precision procedures, is pleased to announce the appointment of Ulrik Berthelsen as its new Chief Executive Officer, effective 12 May 2025. With a distinguished background in the medical technology sector...

The 2025 annual general meeting in Stille AB was held on Wednesday, May 7, 2025, on Norrlandsgatan 11 in Stockholm. The main resolutions passed at the annual general meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the annual general meeting and the complete proposals, which are available on the company’s website...

Stille AB (publ) informs that Niklas Carlén has decided to step down from his position as Chief Financial Officer (CFO) of Stille to pursue a new opportunity outside the company. "I would like to thank Niklas for his significant contributions over the past five years and wish him all the best in his future endeavors. He has played an important role in many key initiatives at Stille, including...

Stille AB (publ) today presents the report for the first quarter 2025. Revenue amounted to 129.3 MSEK (139.7) impacted by temporary delivery restrictions and the phase-out of non-strategic products.“Stille starts 2025 with a quarter marked by temporary challenges.” says Torbjörn Sköld but also points out,“Order intakeremained strong, in line with financial targets, providing...

Stille AB holds its annual general meeting on Wednesday, May 7, 2025, at 13:00 CEST, at Bygget Fest & Konferens on Norrlandsgatan 11 in Stockholm, Sweden. Registration starts at 12:30 CEST. REQUIREMENTS FOR PARTICIPATION Shareholders wishing to attend the meeting shall: Notification of attendance may be made in writing to the company on the address Stille AB, Att: Annual general meeting 2025, Ekbacken...

Today, Stille AB publishes the annual report for 2024. The report can be found on the company website www.stille.se. A full translated version in English will be provided on Stille’s website latest April 29th. Torshälla, April 4th, 2025. Contact DetailsTorbjörn SköldCEO & President+46 (0)70 316 63 91 | torbjorn.skold@stille.se About UsStille AB (publ) develops, manufactures...

Stille AB (publ) today presents the report for the fourth quarter and full year 2024. Revenue amounted to MSEK 159.8 (77.3) driven by strong organic growth in surgical instruments, the successful acquisition of Fehling and solid growth in the US. Total growth amounted to 106.4 percent, of which 22.0 percent was organic growth.“Earnings growth remains solid with an adjusted EBITDA margin of 28.4...

Stille AB (publ) announces the Nomination Committee's proposal for a new board composition for the 2025 Annual General Meeting. Chairman of the Board Lars Kvarnhem has declined re-election, and Jón Sigurdsson is proposed as the new Chairman of the Board. The Nomination Committee proposes the re-election of Per Carlsson, Yonna Olsson, Victor Steien, and Jens Viebke, and that Jón Sigurdsson...

Torbjörn Sköld has informed the board of his intentions to leave his role as CEO in June 2025 to focus on new professional opportunities. Torbjörn Sköld has a notice period of six months and will continue in his current role during that time. The board has now begun the process of recruiting his successor. "Torbjörn has played a central role in further developing and strengthening...